Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study

Main Article Content

Gordon Sussman
Jacques Hebert
Wayne Gulliver
Charles Lynde
William H Yang
Olivier Chambenoit
Antonio Vieira
Frederica DeTakaosy
Lenka Rihakova


urticaria, omalizumab, chronic urticaria, biologic therapy


Abstract not available


Disclosures: Study sponsored by Novartis.


Copyright 2018 SKIN

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

<< < 1 2